AzTrials
AzTrials

Patellofemoral Pain, PFPNCT07384858

Effects of Attentional Focus Strategies During Isokinetic Quadriceps Training on Strength and Functional Performance in Individuals With Patellofemoral Pain Syndrome.

A study testing Internal focus group and External focus in people with Patellofemoral Pain, PFP, run by Istanbul University - Cerrahpasa at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Patellofemoral pain syndrome (PFPS) is a multifactorial musculoskeletal condition that is common particularly among young and physically active individuals, negatively affecting activities of daily living and physical performance. Read more about this study

Who is it for?
Ages 18 to 45 years
Conditions the study is for
Patellofemoral Pain, PFP
What is being tested?
Internal focus group and External focus
Could I receive a placebo?
No, everyone receives an active treatment
How many people
36 participants
Where
1 siteTurkey (Türkiye)
Study dates
2 Feb 2026to 30 Jul 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 45 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • Aged between 18 and 45 years.
  • Diagnosed with patellofemoral pain syndrome (PFPS).
  • Anterior or retropatellar knee pain persisting for at least four weeks with a VAS score > 3.
  • Pain exacerbated by at least two functional activities (e.g., squatting, stair climbing, prolonged sitting).
  • Willing to regularly participate in the 6-week program throughout the study period.

Who cannot join

  • History of patellar subluxation or dislocation.
  • Anterior or posterior cruciate ligament insufficiency.
  • Lower extremity fractures.
  • Neurological or systemic musculoskeletal disorders.
  • Rheumatoid arthritis or other inflammatory joint diseases.
  • History of knee surgery, meniscal injury, or any other underlying musculoskeletal condition that would prevent the participant from performing the exercises.
Show all 9Show fewer
  • Pregnancy or postpartum period.
  • Participation in a similar exercise program within the last 3 months.
  • Radiographic evidence of osteoarthritis classified as Kellgren-Lawrence grade 2 or higher.

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Istanbul University-Cerrahpasa

    Istanbul

Other trials in Turkey (Türkiye)

About this study

Patellofemoral pain syndrome (PFPS) is a multifactorial musculoskeletal condition that is common particularly among young and physically active individuals, negatively affecting activities of daily living and physical performance. Although exercise therapy is considered the gold standard in the management of PFPS, there is limited evidence regarding the effectiveness of motor learning strategies applied during exercise. This study aims to shed light on how motor learning approaches can be optimized in clinical rehabilitation by comparing the effects of internal and external focus strategies used during exercise on muscle activation, functional performance, and pain.

This research will make a methodological contribution to the literature through the objective evaluation of muscle mechanical properties using isokinetic assessment and the MyotonPRO device. The findings are expected to clarify the effects of attentional focus strategies on therapeutic outcomes in PFPS rehabilitation and have the potential to provide an evidence-based guide for physiotherapy practice. In this way, the study may contribute to the development of new approaches aimed at improving both clinical effectiveness and patient adherence.

Being tested
Internal focus group, External focus
Medical subject headings
Patellofemoral Pain Syndrome

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Internal focus groupOther

    Internal focus refers to directing attention to one's own body movements or muscle activity while performing a task (e.g., focusing on contracting a specific muscle). During isokinetic strength exercises, this group is instructed with commands such as: "Tighten your quadriceps" and "Straighten your knee."

  • External focusOther

    External focus refers to directing attention to the effect of a movement on the environment or an external object, rather than on the body itself. During isokinetic exercise, this group is given the instruction: "Increase and maintain the performance indicator on the screen."

Study groups in NCT07384858
Study groupRoleWhat they receive
Internal focusExperimentalNot described
Receives: Other: Internal focus group
External focusExperimentalNot described
Receives: Other: External focus

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Kujala Patellofemoral Pain Score

    Kujala Patellofemoral Pain Score is a valid and reliable self-reported outcome measure specific to patellofemoral pain syndrome that assesses knee function and pain-related limitations during daily activities.

    The total score ranges from 0 to 100, with higher scores indicating better knee function and fewer symptoms.

    Measured: baseline

  2. Kujala Patellofemoral Pain Score

    Kujala Patellofemoral Pain Score is a valid and reliable self-reported outcome measure specific to patellofemoral pain syndrome that assesses knee function and pain-related limitations during daily activities.

    The total score ranges from 0 to 100, with higher scores indicating better knee function and fewer symptoms.

    Measured: Week 3 of the Treatment

  3. Kujala Patellofemoral Pain Score

    Kujala Patellofemoral Pain Score is a valid and reliable self-reported outcome measure specific to patellofemoral pain syndrome that assesses knee function and pain-related limitations during daily activities.

    The total score ranges from 0 to 100, with higher scores indicating better knee function and fewer symptoms.

    Measured: Week 6 of the Treatment

Secondary outcomes (21)
  1. Visual Analog Scale

    Visual Analog Scale (VAS) is a simple and reliable tool used to assess the intensity of knee pain. Participants rate their pain on a 0 to 10 cm scale, with higher scores indicating greater pain severity. It was used to evaluate changes in pain before and after exercise.

    Measured: baseline

  2. Visual Analog Scale

    Visual Analog Scale (VAS) is a simple and reliable tool used to assess the intensity of knee pain. Participants rate their pain on a 0 to 10 cm scale, with higher scores indicating greater pain severity. It was used to evaluate changes in pain before and after exercise.

    Measured: Week 3 of the Treatment

  3. Visual Analog Scale

    Visual Analog Scale (VAS) is a simple and reliable tool used to assess the intensity of knee pain. Participants rate their pain on a 0 to 10 cm scale, with higher scores indicating greater pain severity. It was used to evaluate changes in pain before and after exercise.

    Measured: Week 6 of the Treatment

  4. Isokinetic Muscle Strength Assessment (Isoforce)

    Muscle performance will be objectively evaluated by measuring concentric strength values of the quadriceps muscle.

    Measured: baseline

  5. Isokinetic Muscle Strength Assessment (Isoforce)

    Muscle performance will be objectively evaluated by measuring concentric strength values of the quadriceps muscle.

    Measured: Week 3 of the Treatment

  6. Isokinetic Muscle Strength Assessment (Isoforce)

    Muscle performance will be objectively evaluated by measuring concentric strength values of the quadriceps muscle.

    Measured: Week 6 of the Treatment

  7. Muscle Tone

    Muscle tone was assessed using the MyotonPRO device, expressed in Hertz (Hz), with higher values indicating increased resting muscle tone.

    Measured: baseline

  8. Muscle Tone

    Muscle tone was assessed using the MyotonPRO device, expressed in Hertz (Hz), with higher values indicating increased resting muscle tone.

    Measured: Week 3 of the Treatment

  9. Muscle Tone

    Muscle tone was assessed using the MyotonPRO device, expressed in Hertz (Hz), with higher values indicating increased resting muscle tone.

    Measured: Week 6 of the Treatment

  10. Muscle Stiffness

    Muscle stiffness was measured using the MyotonPRO device, expressed in Newton per meter (N/m), with higher values indicating greater muscle stiffness.

    Measured: baseline

  11. Muscle Stiffness

    Muscle stiffness was measured using the MyotonPRO device, expressed in Newton per meter (N/m), with higher values indicating greater muscle stiffness.

    Measured: Week 3 of the Treatment

  12. Muscle Stiffness

    Muscle stiffness was measured using the MyotonPRO device, expressed in Newton per meter (N/m), with higher values indicating greater muscle stiffness.

    Measured: Week 6 of the Treatment

  13. Muscle Elasticity

    Muscle elasticity was evaluated using the MyotonPRO device, expressed as logarithmic decrement, with lower values indicating better elastic properties.

    Measured: baseline

  14. Muscle Elasticity

    Muscle elasticity was evaluated using the MyotonPRO device, expressed as logarithmic decrement, with lower values indicating better elastic properties.

    Measured: Week 3 of the Treatment

  15. Muscle Elasticity

    Muscle elasticity was evaluated using the MyotonPRO device, expressed as logarithmic decrement, with lower values indicating better elastic properties.

    Measured: Week 6 of the Treatment

  16. Step-Down Test

    Step-Down Test was used to assess lower-extremity control and functional performance. Participants were instructed to perform as many step-down repetitions as possible within 30 seconds. Performance was recorded as the number of completed repetitions, with higher scores indicating better functional capacity and dynamic knee stability.

    Measured: baseline

  17. Step-Down Test

    Step-Down Test was used to assess lower-extremity control and functional performance. Participants were instructed to perform as many step-down repetitions as possible within 30 seconds. Performance was recorded as the number of completed repetitions, with higher scores indicating better functional capacity and dynamic knee stability.

    Measured: Week 3 of the Treatment

  18. Step-Down Test

    Step-Down Test was used to assess lower-extremity control and functional performance. Participants were instructed to perform as many step-down repetitions as possible within 30 seconds. Performance was recorded as the number of completed repetitions, with higher scores indicating better functional capacity and dynamic knee stability.

    Measured: Week 6 of the Treatment

  19. Single-Leg Hop Test

    Single-Leg Hop Test was used to assess functional performance and dynamic knee stability. Participants were instructed to perform a maximal forward hop on the affected limb. The hop distance was measured in centimeters (cm), with greater distances indicating better functional performance.

    Measured: baseline

  20. Single-Leg Hop Test

    Single-Leg Hop Test was used to assess functional performance and dynamic knee stability. Participants were instructed to perform a maximal forward hop on the affected limb. The hop distance was measured in centimeters (cm), with greater distances indicating better functional performance.

    Measured: Week 3 of the Treatment

  21. Single-Leg Hop Test

    Single-Leg Hop Test was used to assess functional performance and dynamic knee stability. Participants were instructed to perform a maximal forward hop on the affected limb. The hop distance was measured in centimeters (cm), with greater distances indicating better functional performance.

    Measured: Week 6 of the Treatment

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Feb 2026
  2. Study start2 Feb 2026
  3. Primary completion30 Jul 2026
  4. Study completion30 Jul 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
36 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07384858
Sponsor's protocol ID
2025/714
Status last verified
Aug 2026
First submitted
17 Dec 2025
Last updated
18 Aug 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing Internal focus group and External focus in people with Patellofemoral Pain, PFP, run by Istanbul University - Cerrahpasa at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 18 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Kujala Patellofemoral Pain Score (time frame: baseline). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Aug 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in